Seeking Alpha

Perrigo (PRGO +1.6%) files an Abbreviated New Drug Application with the FDA for albuterol...

Perrigo (PRGO +1.6%) files an Abbreviated New Drug Application with the FDA for albuterol sulfate HFA inhalation aerosol, a generic version of Teva Pharmaceutical's (TEVA +1%) ProAir HFA. The filing involves contributions from both PRGO and Catalent Pharma Solutions, who partnered on the development. TEVA claims the application violates its patent on the drug, and yesterday it filed suit against both companies in U.S. District Court alleging patent infringement.
Comments (1)
  • Goeleven
    , contributor
    Comments (629) | Send Message
     
    I will wait the results from U.S. District Court.
    6 Sep 2012, 02:40 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector